<DOC>
	<DOCNO>NCT00333918</DOCNO>
	<brief_summary>The primary objective study investigate efficacy safety bromfenac ophthalmic solution treatment ocular inflammation pain subject undergo cataract extraction intraocular lens implantation .</brief_summary>
	<brief_title>Safety/Efficacy Bromfenac Ophthalmic Solution Ocular Inflammation Pain Associated With Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Scheduled unilateral cataract surgery ophthalmic surgical procedure plan cataract surgery Agree return require visit Agree avoid disallow medication Known hypersensitivity bromfenac salicylate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Cataract Extraction</keyword>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
</DOC>